Ajax-Loading

Novartis AG - Short Term Debt

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Short-Term-Debt" stands at 7.78 Billion United States Dollars as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Short Term Debt" stands at 7.78 Billion USD. This represents a decrease of -9.20 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.25 percent compared to the value the year prior.
The 1 year change in percent is 14.25.
The 3 year change in percent is 6.59.
The 5 year change in percent is -22.11.
The 10 year change in percent is -16.20.

The Serie's long term average value is 8.35 Billion United States Dollars. It's latest available value, on 09/30/2025, is 6.73 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2012, to it's latest available value, on 09/30/2025, is +55.15%.
The Serie's change in percent from it's maximum value, on 03/31/2011, to it's latest available value, on 09/30/2025, is -53.05%.

Short Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Short Term Debt905,699,262,464.00
LogoJohnson & Johnson - Short Term Debt486,508,953,600.00
LogoAbbVie Inc - Short Term Debt399,570,305,024.00
LogoRoche Holding AG - Short Term Debt317,433,206,677.55
LogoAstraZeneca PLC - Short Term Debt280,205,508,085.11